Why are potential pain therapies getting lost in translation?
It is estimated that 1.5 billion people worldwide suffer from Chronic pain. While research has seen tremendous advances in our understanding of pain...
Monitoring pain in EAE animals experiencing paralysis
Many neurodegenerative diseases such as Multiple Sclerosis, ALS, and Rhett Syndrome involve paralysis. When developing new treatments, it is...
3 ways to improve clinical relevance of preclinical CNS data
The success rate from first candidate to market launch is less than 1%, requiring approximately 22 hits for every drug launched. Within...
Pain Studies In Pig: advantages for nerve blocks, local & systemic therapies
MD Biosciences lab has an exclusive expertise in pain studies in the pig. Our scientists have developed an acute model and a neuropathic model in...
Weekly Science Blog: Possible Therapies for Spinal Cord Injuries, Reversal for Inflammatory Diseases and More!
It's Tuesday, which means MD Biosciences is providing coverage of the latest fascinating and innovative discoveries happening all over the world...
MDB Neuropathic Pain Porcine Model Publication Featured in Neurobiology of Pain Journal
MDB Scientists recently published a paper titled “Human-like cutaneous neuropathologies associated with a porcine model of peripheral neuritis: a...
Behavioral Research Assessments & Applications: Quantify Cognitive, Emotional, Sensory & Motor Functions
Neurological diseases often result in a combination of motor and cognitive deficits. Thus, behavioral assessments in conjunction with physiological...
Glatiramer Acetate (Copaxone® Generics) and Batch Release Testing in MS/EAE at MD Biosciences
MDB Gains OECD-GLP certification for In Vivo Glatiramer Acetate Batch Release Testing Services
Why the Pig is a Good Preclinical Model for Wound Healing
There are many options for preclinical wound healing research. All studies are designed to predict how a particular treatment will behave in a human...